Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page footer has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/template version refresh without altering the clinical trial record content.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded: Revision v3.5.2; Deleted: Revision v3.5.0.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check61 days agoChange Detected- The page shows a revision label updated from v3.4.2 to v3.4.3, a minor site metadata update that does not alter study content or functionality.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 has been added. The notices about government funding and the prior Revision: v3.4.1 have been removed.SummaryDifference0.3%

- Check97 days agoChange DetectedResults were posted and key endpoints (PFS, ORR, OS, DOR) and health-related QoL data were added, with RECIST criteria and cross-over details described.SummaryDifference2%

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.